Exploratory Pharmacokinetic Study of Pegylated Interferon Alfa-2b Aerosolized Inhalation Administration
Aerosolized PEG IFNα-2b demonstrated increased drug exposure and retention in the lower respiratory tract compared to standard IFNα-2b, suggesting potential therapeutic advantages such as reduced dosing frequency. Further studies are warranted to explore enhanced clinical outcomes.
Authors
- Haihua Wu (ORCID: https://orcid.org/0000-0003-0295-1822)
- Fan Zou (ORCID: https://orcid.org/0000-0002-4471-2865)
- Hee Ho Chu (ORCID: https://orcid.org/0000-0002-3903-0026)
- Yalin Yin (ORCID: https://orcid.org/0000-0002-7919-9571)
Institutions
- Protein Express (United States) (US)
- Xiamen Tobacco Industry (China) (CN)
Publication Details
- Journal
- Journal of Aerosol Medicine and Pulmonary Drug Delivery
- Published
- 2026-02-19
- DOI
- https://doi.org/10.1177/19412711251370951
- Citations
- 1
- Primary Topic
- Inhalation and Respiratory Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.00